Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001081182 | SCV000262067 | benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224531 | SCV000281313 | benign | not provided | 2015-12-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000224531 | SCV000530499 | benign | not provided | 2018-05-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16720663, 25296579, 17594715) |
Personalized Diabetes Medicine Program, |
RCV000445518 | SCV000536984 | benign | Monogenic diabetes | 2019-02-22 | criteria provided, single submitter | research | ACMG criteria: BP4 (9 predictors; Revel score 0.007), BS2 (18 homozygotes in gnomAD), BP1 (missense in gene with truncating mutations), BA1 (1.4% in European gnomAD; 1.1% in ESP); [InVitae, Partners & Childrens Mercy say benign but no longer using BP6]= benign |
Laboratory for Molecular Medicine, |
RCV000434271 | SCV000711844 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Asn2944Lys in exon 10 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 1.38% (921/66738) of European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs35062203). |
Ambry Genetics | RCV002372205 | SCV002683422 | benign | Cardiovascular phenotype | 2018-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000224531 | SCV002822667 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BS1, BS2 |
ARUP Laboratories, |
RCV001081182 | SCV004563042 | benign | Alstrom syndrome | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000224531 | SCV001800093 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000434271 | SCV001921989 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000434271 | SCV001932946 | benign | not specified | no assertion criteria provided | clinical testing |